« FDA Approvals - Schering-Plough Announces FDA Approval Of PEGINTRON(TM) And REBETOL(R) Combination Therapy | Main | FDA Teams With WebMD For New Online Consumer Health Information »

Glaxo s Advair, AstraZeneca s Symbicort Pass FDA Panel Scrutiny (Bloomberg) Dec.


Glaxo s Advair, AstraZeneca s Symbicort Pass FDA Panel Scrutiny (Bloomberg)
Dec. 11 (Bloomberg) -- GlaxoSmithKline Plc s top-selling Advair and AstraZeneca Plc s Symbicort should remain available for asthma patients, a U.S. panel said, though studies suggest the drugs may increase the risk of death or hospitalizations.
 

©2006 FDA-News.com. All rights reserved.